Immune checkpoint inhibitors (ICIs) are a type of immunotherapy or cancer treatment that targets specific immune cells known as T cells, which are responsible for eliminating infection. In cancer, T ...

More health systems across the U.S. are offering monoclonal antibody treatment as a way of fighting COVID-19 infection, but how exactly do the treatments work, and how effective are they in reducing ...

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...

This review focuses on patient care tips and practices for the care of patients with B-NHL or MM receiving bispecific antibody therapy.